{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T20:20:26Z","timestamp":1783455626110,"version":"3.55.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"iPRIME program (Else Kr\u00f6ner-Fresenius-Stiftung) at the University Medical Center Hamburg-Eppendorf"},{"name":"DFG Collaborative Research Center 1648","award":["512741711"],"award-info":[{"award-number":["512741711"]}]},{"name":"DFG Collaborative Research Center 1648","award":["512741711"],"award-info":[{"award-number":["512741711"]}]},{"name":"DFG Collaborative Research Center 1648","award":["512741711"],"award-info":[{"award-number":["512741711"]}]},{"name":"DFG Collaborative Research Center 1648","award":["512741711"],"award-info":[{"award-number":["512741711"]}]},{"name":"DFG Collaborative Research Center 1648","award":["512741711"],"award-info":[{"award-number":["512741711"]}]},{"name":"DFG Collaborative Research Center 1648","award":["512741711"],"award-info":[{"award-number":["512741711"]}]},{"name":"DFG Collaborative Research Center 1648","award":["512741711"],"award-info":[{"award-number":["512741711"]}]},{"name":"DFG Collaborative Research Center 1648","award":["512741711"],"award-info":[{"award-number":["512741711"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Viruses"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Data on MPXV-specific T-cell responses at the single-peptide level remain limited in patients with mpox and in MVA-BN vaccinees. Here, we characterized the breadth and specificity of MPXV-specific T-cell responses at the single-peptide level after in vitro expansion with overlapping 20-mer peptides spanning the MPXV proteins H3L, A35R, and B6R. The study included 28 adult males: 15 with a history of mpox (including 6 with additional MVA-BN vaccination), 7 MVA-BN-only vaccinees, and 6 unexposed participants. All mpox and MVA-BN participants responded to at least one H3L peptide, indicating broad immunogenicity, while responses to A35R and B6R were more common in the mpox group. Notably, the breadth of B6R-specific CD4\n                    <jats:sup>+<\/jats:sup>\n                    T-cell responses correlated with hybrid immunity (\n                    <jats:italic>r<\/jats:italic>\n                    \u2009=\u20090.6;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.02). Interestingly, MVA-BN and mpox individuals demonstrated distinct immunodominant patterns: H3L_251\u2013270 and H3L_211\u2013230 were mainly recognized among mpox individuals, whereas MVA-BN recognized H3L_221\u2013240 more frequently. High-affinity HLA binding to multiple H3L peptides suggests broad population coverage. Additional immunogenetic analysis revealed a shared TRBV15 clonotype in about 50% of mpox cases. In summary, these findings highlight H3L as a potential vaccine target, guiding the development of next-generation multi-antigen MPXV vaccines to elicit comprehensive T-cell immunity.\n                  <\/jats:p>","DOI":"10.1038\/s44298-026-00205-5","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T18:23:47Z","timestamp":1783448627000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["MPXV H3L elicits broadly directed CD4 T cell responses in mpox patients and MVA vaccinees"],"prefix":"10.1038","volume":"4","author":[{"given":"David","family":"da Fonseca Ara\u00fajo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Schulthei\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon","family":"Cords","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Karsten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Woost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Grobecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Westphal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liz","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"L\u00fctgehetmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Pfefferle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"Degen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Peine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Schmiedel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna-Marie","family":"Weichel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marylyn","family":"Addo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Sette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Sidney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mascha","family":"Binder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Schulze zur Wiesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"key":"205_CR1","doi-asserted-by":"publisher","first-page":"114209","DOI":"10.1016\/j.isci.2025.114209","volume":"28","author":"AL Rupp","year":"2025","unstructured":"Rupp, A. L., Meister, J. P., Schulze Zur Wiesch, J. & Meister, T. L. From skin lesions to multi-organ involvement: organ tropism and pathogenesis of mpox virus. iScience 28, 114209 (2025).","journal-title":"iScience"},{"key":"205_CR2","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1093\/cid\/cit703","volume":"58","author":"AM McCollum","year":"2014","unstructured":"McCollum, A. M. & Damon, I. K. Human monkeypox. Clin. Infect. Dis. 58, 260\u2013267 (2014).","journal-title":"Clin. Infect. Dis."},{"key":"205_CR3","doi-asserted-by":"publisher","first-page":"102855","DOI":"10.1016\/j.jaut.2022.102855","volume":"131","author":"N Kumar","year":"2022","unstructured":"Kumar, N., Acharya, A., Gendelman, H. E. & Byrareddy, S. N. The 2022 outbreak and the pathobiology of the monkeypox virus. J. Autoimmun. 131, 102855 (2022).","journal-title":"J. Autoimmun."},{"key":"205_CR4","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S0014-5793(01)03144-1","volume":"509","author":"SN Shchelkunov","year":"2001","unstructured":"Shchelkunov, S. N. et al. Human monkeypox and smallpox viruses: genomic comparison. FEBS Lett. 509, 66\u201370 (2001).","journal-title":"FEBS Lett."},{"key":"205_CR5","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/j.1600-065X.2008.00691.x","volume":"225","author":"JR Weaver","year":"2008","unstructured":"Weaver, J. R. & Isaacs, S. N. Monkeypox virus and insights into its immunomodulatory proteins. Immunol. Rev. 225, 96\u2013113 (2008).","journal-title":"Immunol. Rev."},{"key":"205_CR6","doi-asserted-by":"publisher","first-page":"e0010141","DOI":"10.1371\/journal.pntd.0010141","volume":"16","author":"EM Bunge","year":"2022","unstructured":"Bunge, E. M. et al. The changing epidemiology of human monkeypox-A potential threat? A systematic review. PLoS Negl. Trop. Dis. 16, e0010141 (2022).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"205_CR7","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1038\/s41591-022-01907-y","volume":"28","author":"J Isidro","year":"2022","unstructured":"Isidro, J. et al. Phylogenomic characterization and signs of microevolution in the 2022 multi-country outbreak of monkeypox virus. Nat. Med. 28, 1569\u20131572 (2022).","journal-title":"Nat. Med."},{"key":"205_CR8","doi-asserted-by":"publisher","first-page":"734","DOI":"10.15585\/mmwr.mm7122e1","volume":"71","author":"AK Rao","year":"2022","unstructured":"Rao, A. K. et al. Use of JYNNEOS (smallpox and monkeypox vaccine, live, nonreplicating) for preexposure vaccination of persons at risk for occupational exposure to orthopoxviruses: recommendations of the Advisory Committee on Immunization Practices\u2014United States, 2022. Morb. Mortal. Wkly Rep. 71, 734\u2013742 (2022).","journal-title":"Morb. Mortal. Wkly Rep."},{"key":"205_CR9","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3201\/eid2002.130118","volume":"20","author":"JR Kugelman","year":"2014","unstructured":"Kugelman, J. R. et al. Genomic variability of monkeypox virus among humans, Democratic Republic of the Congo. Emerg. Infect. Dis. 20, 232\u2013239 (2014).","journal-title":"Emerg. Infect. Dis."},{"key":"205_CR10","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nrmicro1099","volume":"3","author":"G McFadden","year":"2005","unstructured":"McFadden, G. Poxvirus tropism. Nat. Rev. Microbiol 3, 201\u2013213 (2005).","journal-title":"Nat. Rev. Microbiol"},{"key":"205_CR11","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1016\/j.chom.2022.11.003","volume":"30","author":"A Grifoni","year":"2022","unstructured":"Grifoni, A. et al. Defining antigen targets to dissect vaccinia virus and monkeypox virus-specific T cell responses in humans. Cell Host Microbe. 30, 1662\u20131670.e1664 (2022).","journal-title":"Cell Host Microbe."},{"key":"205_CR12","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/bs.aivir.2016.07.001","volume":"97","author":"A Volz","year":"2017","unstructured":"Volz, A. & Sutter, G. Modified vaccinia virus Ankara: history, value in basic research, and current perspectives for vaccine development. Adv. Virus Res. 97, 187\u2013243 (2017).","journal-title":"Adv. Virus Res."},{"key":"205_CR13","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/nm1261","volume":"11","author":"Y Edghill-Smith","year":"2005","unstructured":"Edghill-Smith, Y. et al. Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus. Nat. Med. 11, 740\u2013747 (2005).","journal-title":"Nat. Med."},{"key":"205_CR14","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s00253-025-13466-6","volume":"109","author":"IH Huang","year":"2025","unstructured":"Huang, I. H. et al. Monkeypox virus H3L protein as the target antigen for developing neutralizing antibody and serological assay. Appl. Microbiol. Biotechnol. 109, 80 (2025).","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"205_CR15","doi-asserted-by":"publisher","first-page":"105957","DOI":"10.1016\/j.isci.2023.105957","volume":"26","author":"R Yefet","year":"2023","unstructured":"Yefet, R. et al. Monkeypox infection elicits strong antibody and B cell response against A35R and H3L antigens. iScience 26, 105957 (2023).","journal-title":"iScience"},{"key":"205_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s40249-025-01280-1","volume":"14","author":"J Liu","year":"2025","unstructured":"Liu, J. et al. Immunogenicity of monkeypox virus surface proteins and cross-reactive antibody responses in vaccinated and infected individuals: implications for vaccine and therapeutic development. Infect. Dis. Poverty 14, 12 (2025).","journal-title":"Infect. Dis. Poverty"},{"key":"205_CR17","doi-asserted-by":"publisher","first-page":"105392","DOI":"10.1016\/j.ebiom.2024.105392","volume":"109","author":"T Kong","year":"2024","unstructured":"Kong, T. et al. Single-chain A35R-M1R-B6R trivalent mRNA vaccines protect mice against both mpox virus and vaccinia virus. EBioMedicine 109, 105392 (2024).","journal-title":"EBioMedicine"},{"key":"205_CR18","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2025.2535485","volume":"14","author":"Y Wang","year":"2025","unstructured":"Wang, Y. et al. A bivalent Mpox nanoparticle vaccine induces robust immune response and provides long-lasting protection against vaccinia virus challenge. Emerg. Microbes Infect. 14, 2535485 (2025).","journal-title":"Emerg. Microbes Infect."},{"key":"205_CR19","doi-asserted-by":"publisher","first-page":"114269","DOI":"10.1016\/j.celrep.2024.114269","volume":"43","author":"T Ye","year":"2024","unstructured":"Ye, T. et al. Polyvalent mpox mRNA vaccines elicit robust immune responses and confer potent protection against vaccinia virus. Cell Rep. 43, 114269 (2024).","journal-title":"Cell Rep."},{"key":"205_CR20","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.it.2025.04.002","volume":"46","author":"H Yu","year":"2025","unstructured":"Yu, H., Resch, W. & Moss, B. Poxvirus structural biology for application to vaccine design. Trends Immunol. 46, 455\u2013470 (2025).","journal-title":"Trends Immunol."},{"key":"205_CR21","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1128\/JVI.74.7.3353-3365.2000","volume":"74","author":"CL Lin","year":"2000","unstructured":"Lin, C. L., Chung, C. S., Heine, H. G. & Chang, W. Vaccinia virus envelope H3L protein binds to cell surface heparan sulfate and is important for intracellular mature virion morphogenesis and virus infection in vitro and in vivo. J. Virol. 74, 3353\u20133365 (2000).","journal-title":"J. Virol."},{"key":"205_CR22","doi-asserted-by":"publisher","first-page":"4192","DOI":"10.1128\/JVI.72.5.4192-4204.1998","volume":"72","author":"RL Roper","year":"1998","unstructured":"Roper, R. L., Wolffe, E. J., Weisberg, A. & Moss, B. The envelope protein encoded by the A33R gene is required for formation of actin-containing microvilli and efficient cell-to-cell spread of vaccinia virus. J. Virol. 72, 4192\u20134204 (1998).","journal-title":"J. Virol."},{"key":"205_CR23","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1128\/JVI.80.1.306-313.2006","volume":"80","author":"RL Roper","year":"2006","unstructured":"Roper, R. L. Characterization of the vaccinia virus A35R protein and its role in virulence. J. Virol. 80, 306\u2013313 (2006).","journal-title":"J. Virol."},{"key":"205_CR24","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41590-023-01715-7","volume":"25","author":"H Wang","year":"2024","unstructured":"Wang, H. et al. Rational design of a \u2018two-in-one\u2019 immunogen DAM drives potent immune response against mpox virus. Nat. Immunol. 25, 307\u2013315 (2024).","journal-title":"Nat. Immunol."},{"key":"205_CR25","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/978-1-4615-5331-1_51","volume":"440","author":"GL Smith","year":"1998","unstructured":"Smith, G. L. & Vanderplasschen, A. Extracellular enveloped vaccinia virus. Entry, egress, and evasion. Adv. Exp. Med. Biol. 440, 395\u2013414 (1998).","journal-title":"Adv. Exp. Med. Biol."},{"key":"205_CR26","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.4049\/jimmunol.175.6.3603","volume":"175","author":"J Schulze zur Wiesch","year":"2005","unstructured":"Schulze zur Wiesch, J. et al. Broad repertoire of the CD4+ Th cell response in spontaneously controlled hepatitis C virus infection includes dominant and highly promiscuous epitopes. J. Immunol. 175, 3603\u20133613 (2005).","journal-title":"J. Immunol."},{"key":"205_CR27","doi-asserted-by":"publisher","first-page":"e1009842","DOI":"10.1371\/journal.ppat.1009842","volume":"17","author":"J Heide","year":"2021","unstructured":"Heide, J. et al. Broadly directed SARS-CoV-2-specific CD4+ T cell response includes frequently detected peptide specificities within the membrane and nucleoprotein in patients with acute and resolved COVID-19. PLoS Pathog. 17, e1009842 (2021).","journal-title":"PLoS Pathog."},{"key":"205_CR28","doi-asserted-by":"publisher","first-page":"e1410","DOI":"10.1002\/cti2.1410","volume":"11","author":"H Karsten","year":"2022","unstructured":"Karsten, H. et al. High-resolution analysis of individual spike peptide-specific CD4(+) T-cell responses in vaccine recipients and COVID-19 patients. Clin. Transl. Immunol. 11, e1410 (2022).","journal-title":"Clin. Transl. Immunol."},{"key":"205_CR29","doi-asserted-by":"publisher","first-page":"1182504","DOI":"10.3389\/fimmu.2023.1182504","volume":"14","author":"T Westphal","year":"2023","unstructured":"Westphal, T. et al. Evidence for broad cross-reactivity of the SARS-CoV-2 NSP12-directed CD4(+) T-cell response with pre-primed responses directed against common cold coronaviruses. Front. Immunol. 14, 1182504 (2023).","journal-title":"Front. Immunol."},{"key":"205_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-60486-x","volume":"16","author":"S Akther","year":"2025","unstructured":"Akther, S. et al. Genomic epidemiology of mpox virus during the 2022 outbreak in New York City. Nat. Commun. 16, 8354 (2025).","journal-title":"Nat. Commun."},{"key":"205_CR31","doi-asserted-by":"publisher","first-page":"101798","DOI":"10.1016\/j.biologicals.2024.101798","volume":"88","author":"O Dulek","year":"2024","unstructured":"Dulek, O. et al. Computational identification of monkeypox virus epitopes to generate a novel vaccine antigen against Mpox. Biologicals 88, 101798 (2024).","journal-title":"Biologicals"},{"key":"205_CR32","doi-asserted-by":"publisher","first-page":"103353","DOI":"10.1016\/j.isci.2021.103353","volume":"24","author":"TI de Silva","year":"2021","unstructured":"de Silva, T. I. et al. The impact of viral mutations on recognition by SARS-CoV-2 specific T cells. iScience 24, 103353 (2021).","journal-title":"iScience"},{"key":"205_CR33","doi-asserted-by":"publisher","first-page":"eadg3540","DOI":"10.1126\/scitranslmed.adg3540","volume":"15","author":"AW Freyn","year":"2023","unstructured":"Freyn, A. W. et al. An mpox virus mRNA-lipid nanoparticle vaccine confers protection against lethal orthopoxviral challenge. Sci. Transl. Med. 15, eadg3540 (2023).","journal-title":"Sci. Transl. Med."},{"key":"205_CR34","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1007\/s12026-024-09499-0","volume":"72","author":"S Song","year":"2024","unstructured":"Song, S. et al. Analysis of binding and authentic virus-neutralizing activities of immune sera induced by various monkeypox virus antigens. Immunol. Res. 72, 902\u2013907 (2024).","journal-title":"Immunol. Res."},{"key":"205_CR35","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.1365-2249.2007.03401.x","volume":"149","author":"ND Ostrout","year":"2007","unstructured":"Ostrout, N. D. et al. Long-term T cell memory to human leucocyte antigen-A2 supertype epitopes in humans vaccinated against smallpox. Clin. Exp. Immunol. 149, 265\u2013273 (2007).","journal-title":"Clin. Exp. Immunol."},{"key":"205_CR36","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41422-023-00792-5","volume":"33","author":"Z Fang","year":"2023","unstructured":"Fang, Z. et al. Polyvalent mRNA vaccination elicited potent immune response to monkeypox virus surface antigens. Cell Res. 33, 407\u2013410 (2023).","journal-title":"Cell Res."},{"key":"205_CR37","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/s41392-023-01432-5","volume":"8","author":"Y Sang","year":"2023","unstructured":"Sang, Y. et al. Monkeypox virus quadrivalent mRNA vaccine induces immune response and protects against vaccinia virus. Signal Transduct. Target Ther. 8, 172 (2023).","journal-title":"Signal Transduct. Target Ther."},{"key":"205_CR38","doi-asserted-by":"publisher","first-page":"e1013389","DOI":"10.1371\/journal.ppat.1013389","volume":"21","author":"L Zhang","year":"2025","unstructured":"Zhang, L. et al. Multivalent mpox protein nanoparticle vaccines confer cross-protection against orthopoxvirus infection. PLoS Pathog. 21, e1013389 (2025).","journal-title":"PLoS Pathog."},{"key":"205_CR39","doi-asserted-by":"publisher","first-page":"e0025325","DOI":"10.1128\/jvi.00253-25","volume":"99","author":"AL Oom","year":"2025","unstructured":"Oom, A. L. et al. The two-dose MVA-BN mpox vaccine induces a nondurable and low avidity MPXV-specific antibody response. J. Virol. 99, e0025325 (2025).","journal-title":"J. Virol."},{"key":"205_CR40","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/ueg2.12528","volume":"12","author":"P von der Schulenburg","year":"2024","unstructured":"von der Schulenburg, P. et al. High vaccination coverage and infection rate result in a robust SARS-CoV-2-specific immunity in the majority of liver cirrhosis and transplant patients: a single-center cross-sectional study. U. Eur. Gastroenterol. J. 12, 339\u2013351 (2024).","journal-title":"U. Eur. Gastroenterol. J."},{"key":"205_CR41","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.chom.2023.04.015","volume":"31","author":"S Adamo","year":"2023","unstructured":"Adamo, S. et al. Memory profiles distinguish cross-reactive and virus-specific T cell immunity to mpox. Cell Host Microbe. 31, 928\u2013936.e924 (2023).","journal-title":"Cell Host Microbe."},{"key":"205_CR42","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/S1473-3099(23)00352-3","volume":"23","author":"H Cohn","year":"2023","unstructured":"Cohn, H. et al. Mpox vaccine and infection-driven human immune signatures: an immunological analysis of an observational study. Lancet Infect. Dis. 23, 1302\u20131312 (2023).","journal-title":"Lancet Infect. Dis."},{"key":"205_CR43","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/S1473-3099(23)00185-8","volume":"23","author":"AR Raccagni","year":"2023","unstructured":"Raccagni, A. R. et al. Two individuals with potential monkeypox virus reinfection. Lancet Infect. Dis. 23, 522\u2013524 (2023).","journal-title":"Lancet Infect. Dis."},{"key":"205_CR44","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S1473-3099(23)00492-9","volume":"24","author":"A Hazra","year":"2024","unstructured":"Hazra, A. et al. Mpox in people with past infection or a complete vaccination course: a global case series. Lancet Infect. Dis. 24, 57\u201364 (2024).","journal-title":"Lancet Infect. Dis."},{"key":"205_CR45","doi-asserted-by":"publisher","first-page":"e70498","DOI":"10.1002\/jmv.70498","volume":"97","author":"O Calle-Jimenez","year":"2025","unstructured":"Calle-Jimenez, O. et al. Low specific T-cell immunity against Mpox elicited in people with HIV-1 and PrEP users after subcutaneous vaccination compared to natural infection. J. Med. Virol. 97, e70498 (2025).","journal-title":"J. Med. Virol."},{"key":"205_CR46","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/S1473-3099(22)00662-4","volume":"23","author":"C Agrati","year":"2023","unstructured":"Agrati, C. et al. Immunological signature in human cases of monkeypox infection in 2022 outbreak: an observational study. Lancet Infect. Dis. 23, 320\u2013330 (2023).","journal-title":"Lancet Infect. Dis."},{"key":"205_CR47","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/imcb.12019","volume":"96","author":"AR Di Carluccio","year":"2018","unstructured":"Di Carluccio, A. R., Triffon, C. F. & Chen, W. Perpetual complexity: predicting human CD8(+) T-cell responses to pathogenic peptides. Immunol. Cell Biol. 96, 358\u2013369 (2018).","journal-title":"Immunol. Cell Biol."},{"key":"205_CR48","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1007\/s15010-023-01997-x","volume":"51","author":"ST Kroger","year":"2023","unstructured":"Kroger, S. T. et al. Mpox outbreak 2022: an overview of all cases reported to the Cologne Health Department. Infection 51, 1369\u20131381 (2023).","journal-title":"Infection"},{"key":"205_CR49","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.it.2013.10.006","volume":"35","author":"JG Markle","year":"2014","unstructured":"Markle, J. G. & Fish, E. N. SeXX matters in immunity. Trends Immunol. 35, 97\u2013104 (2014).","journal-title":"Trends Immunol."},{"key":"205_CR50","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/978-3-642-30726-3_22","volume":"214","author":"SL Klein","year":"2012","unstructured":"Klein, S. L. Sex differences in prophylaxis and therapeutic treatments for viral diseases. Handb. Exp. Pharmacol. 214, 499\u2013522 (2012).","journal-title":"Handb. Exp. Pharmacol."},{"key":"205_CR51","doi-asserted-by":"publisher","first-page":"5540","DOI":"10.1016\/j.cell.2024.08.043","volume":"187","author":"EM Mucker","year":"2024","unstructured":"Mucker, E. M. et al. Comparison of protection against mpox following mRNA or modified vaccinia Ankara vaccination in nonhuman primates. Cell 187, 5540\u20135553.e5510 (2024).","journal-title":"Cell"},{"key":"205_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-58328-x","volume":"16","author":"W Tai","year":"2025","unstructured":"Tai, W. et al. An mRNA vaccine against monkeypox virus inhibits infection by co-activation of humoral and cellular immune responses. Nat. Commun. 16, 2971 (2025).","journal-title":"Nat. Commun."},{"key":"205_CR53","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.3389\/fimmu.2019.01897","volume":"10","author":"D Simnica","year":"2019","unstructured":"Simnica, D. et al. High-throughput immunogenetics reveals a lack of physiological T cell clusters in patients with autoimmune cytopenias. Front. Immunol. 10, 1897 (2019).","journal-title":"Front. Immunol."},{"key":"205_CR54","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nmeth.3364","volume":"12","author":"DA Bolotin","year":"2015","unstructured":"Bolotin, D. A. et al. MiXCR: software for comprehensive adaptive immunity profiling. Nat. Methods 12, 380\u2013381 (2015).","journal-title":"Nat. Methods"},{"key":"205_CR55","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.immuni.2020.06.024","volume":"53","author":"C Schultheiss","year":"2020","unstructured":"Schultheiss, C. et al. Next-generation sequencing of T and B cell receptor repertoires from COVID-19 patients showed signatures associated with severity of disease. Immunity 53, 442\u2013455.e444 (2020).","journal-title":"Immunity"},{"key":"205_CR56","doi-asserted-by":"publisher","unstructured":"Schultheiss, C. et al. B cells expressing mutated IGHV1-69-encoded antigen receptors related to virus neutralization show lymphoma-like transcriptomes in patients with chronic HCV infection. Hepatol. Commun. 8, https:\/\/doi.org\/10.1097\/HC9.0000000000000503 (2024).","DOI":"10.1097\/HC9.0000000000000503"},{"key":"205_CR57","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1016\/j.molonc.2015.09.003","volume":"9","author":"I Kirsch","year":"2015","unstructured":"Kirsch, I., Vignali, M. & Robins, H. T-cell receptor profiling in cancer. Mol. Oncol. 9, 2063\u20132070 (2015).","journal-title":"Mol. Oncol."}],"container-title":["npj Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44298-026-00205-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44298-026-00205-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44298-026-00205-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T20:01:54Z","timestamp":1783454514000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44298-026-00205-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["205"],"URL":"https:\/\/doi.org\/10.1038\/s44298-026-00205-5","relation":{},"ISSN":["2948-1767"],"issn-type":[{"value":"2948-1767","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"assertion":[{"value":"10 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31"}}